πŸ‡ΊπŸ‡Έ FDA
Patent

US 12214031

Mannheimia haemolytica vector

granted A61KA61K2039/522A61K2039/523

Quick answer

US patent 12214031 (Mannheimia haemolytica vector) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/522, A61K2039/523, A61K2039/5256, A61K2039/543